Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy From a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR).
暂无分享,去创建一个
D. Staskin | D. Shortino | Rachael A. Jankowich | P. Mudd | J. Frankel | S. Varano | Denise D Shortino | Rachael A Jankowich